Fluorinated Isoxazolidinone Scaffold Delivers Apoptosis-Inducing Antiproliferative Leads
- A new series of fluorinated 4-methylideneisoxazolidin-5-one derivatives adds fluorine substituents onto the exocyclic methylidene-lactone-type isoxazolidinone core.
- The fluorinated analogs showed antiproliferative activity against cancer cell lines, with the reported cell-death mechanism attributed to induction of apoptosis.
- Structure-activity comparisons across the fluorinated series highlighted substitution patterns linked to improved potency and selectivity relative to non-fluorinated parent compounds.
💡 Points
An exocyclic methylidene lactone is a classic Michael acceptor shape — before crediting fluorination for the potency gain, I'd rule out plain thiol-reactive cytotoxicity masquerading as 'apoptosis.' Fluorination itself is a cheap, tractable SAR handle for potency/metabolic stability, but with no confirmed target, this stays a phenotypic hit until a pulldown or competition assay lands the binding site.